MAPT and Alzheimer disease: Based on the genetic causes of rare forms of familial AD, which all act to increase Aβ accumulation, and the timing of pathological development where plaque pathology is an early pathological feature preceding appreciable tau pathology by many years, it is widely thought that Aβ is “upstream” of tau in initiating AD pathogenesis [88].